Join members from NHLBI’s SMARTT team on May 28, 2014 (1:00-2:30 pm EST) for a free webinar to hear how three investigators utilized SMARTT services to advance the development of their lead candidates.
Webinar agenda
- Overview of SMARTT
- Translational Investigator presentations:
- Steven Idell, MD, PhD, Vice President for Research at The University of Texas Health Science Center at Tyler
Development of fibrinolysin single chain urokinase plasminogen activator (scuPA) for pleural effusions - Athan Kuliopulos, MD, PhD, Professor of Medicine at Tufts University and Tufts Medical Center
Development of PZ-128 for the prevention of arterial thrombosis in acute coronary syndrome and percutaneous coronary intervention - Barry Coller, MD, Vice President for Medical Affairs and Physician-in-Chief, The Rockefeller University
Development of novel small molecule platelet inhibitors for pre-hospital treatment of myocardial infarction. - Challenges in Early Translational Science: Industry Perspective
- Q&A with SMARTT
Representatives from NHLBI staff and from SMARTT’s regulatory, manufacturing, and pharmacology/toxicology facilities will be available to answer questions.
{iframe}https://www.nhlbismartt.org/?page=webinar.home{/iframe}